SCHEMBL9810967

SCHEMBL9810967

O=C1c2ccccc2-c2ccc(F)c(F)c21

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 7/20 0.48
KMT2A Q03164 7/20 0.48
MAOA P21397 6/20 0.48
MAPT P10636 6/20 0.48
PTPRC P08575 5/20 0.48
S100A4 P26447 4/20 0.48
KDM4E B2RXH2 4/20 0.48
LMNA P02545 3/20 0.48
MAPK1 P28482 3/20 0.48
RECQL P46063 3/20 0.48
SMN1; SMN2 Q16637 3/20 0.48
APAF1 O14727 2/20 0.48
NPC1 O15118 2/20 0.48
TDP2 O95551 2/20 0.48
PLA2G1B P04054 2/20 0.48
POLB P06746 2/20 0.48
PLCG1 P19174 2/20 0.48
PPARG P37231 2/20 0.48
HTT P42858 2/20 0.48
RAB9A P51151 2/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3415942 0.92 MAPT (0.50) MEN1KMT2AMAOAMAPTPTPRC
SCHEMBL8956362 0.85 CYP1A2 (0.46) MEN1KMT2AMAOAMAPTPTPRC
SCHEMBL27551511 0.80 ADORA2A (0.61) MEN1KMT2AMAOAMAPTPTPRC
SCHEMBL11312817 0.80 MAOA (0.56) MEN1KMT2AMAOAMAPTPTPRC
SCHEMBL28863786 0.80 PTPRC (0.46) MEN1KMT2AMAOAMAPTPTPRC
SCHEMBL3418850 0.80 MEN1 (0.55) MEN1KMT2AMAOAMAPTPTPRC
SCHEMBL10599309 0.78 PTGS2 (0.39) MEN1KMT2AMAOAMAPTKDM4E
SCHEMBL2072999 0.78 MAPT (0.52) MEN1KMT2AMAOAMAPTPTPRC
SCHEMBL23199098 0.77 PTGS2 (0.38) MEN1KMT2AMAOAMAPTKDM4E
SCHEMBL11308375 0.76 ALDH1A1 (0.46) MEN1KMT2AMAOAMAPTPTPRC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0092385-B1 HYDANTOIN DERIVATIVES FOR USE IN INHIBITING ALDOSE REDUCTASE ACTIVITY, COMPOSITIONS THEREFOR AND PROCESS FOR PREPARING SPIRO-FLUOREN COMPOUNDS ALCON LABORATORIES, INC. (US) 1991-06-12 EP disclosed
US-4540700-A Treatment of diabetic complications with certain spiro-imidazolidine-diones ALCON LABORATORIES, INC. (US) 1985-09-10 US disclosed
WO-1983003543-A1 METHOD OF INHIBITING ALDOSE REDUCTASE ACTIVITY, COMPOSITIONS THEREFOR AND PROCESS FOR PREPARING SPIRO-FLUOROFLUOREN AND SPIRO-DIFLUOROFLUOREN COMPOUNDS ALCON LAB INC (US) 1983-10-27 WO disclosed
EP-0092385-A2 Hydantoin derivatives for use in inhibiting aldose reductase activity, compositions therefor and process for preparing spiro-fluoren compounds ALCON LABORATORIES, INC. (US) 1983-10-26 EP disclosed